Qyuns Therapeutics Co., Ltd. (HKG:2509)
Hong Kong · Delayed Price · Currency is HKD 16.56
-0.18 (-1.08%)
Oct 22, 2026, 3:57 PM HKT
Qyuns Therapeutics Market Cap
Qyuns Therapeutics has a market cap or net worth of 3.7 billion as of October 21, 2026. It is the 15,168th most valuable company in the world and the 676th biggest in Hong Kong. Its market cap has decreased by 43.83% in one year.
Market Cap
3.70B
Enterprise Value
3.27B
Revenue
1.18B
Global Rank
Country Rank
#676 Hong Kong
PE Ratio
5.91
ChartMarket Cap Chart
Since March 20, 2024, Qyuns Therapeutics's market cap has decreased from 5.02B to 3.70B, a decrease of -26.26%. That is a compound annual growth rate of -11.09%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2026 | 3.70B | -12.68% |
| Dec 31, 2025 | 4.24B | 158.47% |
| Dec 31, 2024 | 1.64B | -67.33% |
| Mar 20, 2024 | 5.02B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Jacobio Pharmaceuticals Group | 4.13B |
| Ocumension Therapeutics | 3.91B |
| TransThera Sciences (Nanjing) | 3.70B |
| Hanx Biopharmaceuticals (Wuhan) | 3.68B |
| Mirxes Holding Company | 3.66B |
| Beijing Luzhu Biotechnology | 3.04B |
| Shanghai Bao Pharmaceuticals | 2.97B |
| Viva Biotech Holdings | 2.85B |